This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Gibril, F. Articles by Jensen, R. T. Search for Related Content PubMed PubMed Citation Articles by Gibril, F. Articles by Jensen, R. T.

Prospective Study of Thymic Carcinoids in Patients with Multiple Endocrine Neoplasia Type 1

Digestive Diseases Branch (F.G., Y-J.C., K.H., L.K.E., B.A., R.T.J.), National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health (NIH); Thoracic Oncology Section (D.S.S.), Surgery Branch, National Cancer Institute, NIH; Molecular Pathogenesis Unit, Surgical Neurology Branch (A.V., Z.Z., I.A.L.) National Institute of Neurological Disorders and Strokes, NIH; Nuclear Medicine Department (J.C.R.) and Diagnostic Radiology Department (A.L.), Warren Grant Magnuson Clinical Center, NIH, Bethesda, Maryland 20892

Address all correspondence and requests for reprints to: Dr. Robert T. Jensen, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Digestive Diseases Branch, Building 10, Room 9C-103, 10 Center Drive, MSC 1804, Bethesda, Maryland 20892-1804. E-mail: robertj{at}bdg10.niddk.nih.gov.

Little is known of the natural history of thymic carcinoids in multiple endocrine neoplasia type 1 (MEN1). This is important because in 1993 they were identified as a frequent cause of death, yet only small retrospective studies and case reports exist. We report results of a prospective study of 85 patients with MEN1 evaluated for pancreatic endocrine tumors and followed over a mean of 8 yr with serial chest computed tomography, magnetic resonance imaging (MRI), chest x-ray, and, since 1994, octreoscans [somatostatin receptor scintigraphy (SRS)]. Seven patients (8%) developed thymic carcinoids. Patients with and without carcinoids did not differ in clinical, laboratory, or MEN1 tumor features, except for male gender and the presence of a gastric carcinoid. All thymic tumors were hormonally inactive. Four thymic carcinoids lacked 11q loss of heterozygosity, although it was found in three pancreatic endocrine tumors. Computed tomography and/or MRI were more sensitive than SRS or chest x-ray in detecting tumors initially or with recurrence. All patients underwent resection of the thymic carcinoid, and in all patients followed more than 1 yr, the tumor recurred. Bone metastases developed in two patients and were detected early only on MRI, not SRS. This study provides information on early thymic carcinoids and allows modifications of existing guidelines to be recommended for their diagnosis, surveillance, and treatment.

Abbreviations: BAO, Basal acid output; CT, computed tomography; 5-HIAA, 5-hydroxyindolacetic acid; LOH, loss of heterozygosity; MEN1, multiple endocrine neoplasia type 1; MRI, magnetic resonance imaging; PET, pancreatic endocrine tumor; SPECT, single photon emission CT; SRS, somatostatin receptor scintigraphy; ZES, Zollinger-Ellison syndrome.

This article has been cited by other articles:

				M. J. Berna, B. Annibale, M. Marignani, T. V. Luong, V. Corleto, A. Pace, T. Ito, D. Liewehr, D. J. Venzon, G. Delle Fave, et al. A Prospective Study of Gastric Carcinoids and Enterochromaffin-Like Cell Changes in Multiple Endocrine Neoplasia Type 1 and Zollinger-Ellison Syndrome: Identification of Risk Factors J. Clin. Endocrinol. Metab., May 1, 2008; 93(5): 1582 - 1591. [Abstract] [Full Text] [PDF]

				A. F. Scarsbrook, R. V. Thakker, J. A. H. Wass, F. V. Gleeson, and R. R. Phillips Multiple Endocrine Neoplasia: Spectrum of Radiologic Appearances and Discussion of a Multitechnique Imaging Approach. RadioGraphics, March 1, 2006; 26(2): 433 - 451. [Abstract] [Full Text] [PDF]

				M. Yano, I. Fukai, Y. Kobayashi, K. Mizuno, A. Konishi, H. Haneda, E. Suzuki, K. Endo, and Y. Fujii ACTH Secreting Thymic Carcinoid Associated With Multiple Endocrine Neoplasia Type 1 Ann. Thorac. Surg., January 1, 2006; 81(1): 366 - 368. [Abstract] [Full Text] [PDF]

				K. M. Hoffmann, F. Gibril, L. K. Entsuah, J. Serrano, and R. T. Jensen Patients with Multiple Endocrine Neoplasia Type 1 with Gastrinomas Have an Increased Risk of Severe Esophageal Disease Including Stricture and the Premalignant Condition, Barrett's Esophagus J. Clin. Endocrinol. Metab., January 1, 2006; 91(1): 204 - 212. [Abstract] [Full Text] [PDF]

				B. V. Duwe, D. H. Sterman, and A. I. Musani Tumors of the Mediastinum Chest, October 1, 2005; 128(4): 2893 - 2909. [Abstract] [Full Text] [PDF]

				S. J. Marx and W. F. Simonds Hereditary Hormone Excess: Genes, Molecular Pathways, and Syndromes Endocr. Rev., August 1, 2005; 26(5): 615 - 661. [Abstract] [Full Text] [PDF]

				P. Ferolla, A. Falchetti, P. Filosso, P. Tomassetti, G. Tamburrano, N. Avenia, G. Daddi, F. Puma, R. Ribacchi, F. Santeusanio, et al. Thymic Neuroendocrine Carcinoma (Carcinoid) in Multiple Endocrine Neoplasia Type 1 Syndrome: The Italian Series J. Clin. Endocrinol. Metab., May 1, 2005; 90(5): 2603 - 2609. [Abstract] [Full Text] [PDF]

				B. Asgharian, M. L. Turner, F. Gibril, L. K. Entsuah, J. Serrano, and R. T. Jensen Cutaneous Tumors in Patients with Multiple Endocrine Neoplasm Type 1 (MEN1) and Gastrinomas: Prospective Study of Frequency and Development of Criteria with High Sensitivity and Specificity for MEN1 J. Clin. Endocrinol. Metab., November 1, 2004; 89(11): 5328 - 5336. [Abstract] [Full Text] [PDF]

				W. Hao, M. C. Skarulis, W. F. Simonds, L. S. Weinstein, S. K. Agarwal, C. Mateo, L. James-Newton, G. R. Hobbs, F. Gibril, R. T. Jensen, et al. Multiple Endocrine Neoplasia Type 1 Variant with Frequent Prolactinoma and Rare Gastrinoma J. Clin. Endocrinol. Metab., August 1, 2004; 89(8): 3776 - 3784. [Abstract] [Full Text] [PDF]

				G. A. Kaltsas, G. M. Besser, and A. B. Grossman The Diagnosis and Medical Management of Advanced Neuroendocrine Tumors Endocr. Rev., June 1, 2004; 25(3): 458 - 511. [Abstract] [Full Text] [PDF]

				S. K. AGARWAL, A LEE BURNS, K. E. SUKHODOLETS, P. A. KENNEDY, V. H. OBUNGU, A. B. HICKMAN, M. E. MULLENDORE, I. WHITTEN, M. C. SKARULIS, W. F. SIMONDS, et al. Molecular Pathology of the MEN1 Gene Ann. N.Y. Acad. Sci., April 1, 2004; 1014(1): 189 - 198. [Abstract] [Full Text] [PDF]

				B. Asgharian, Y.-J. Chen, N. J. Patronas, P. L. Peghini, J. C. Reynolds, A. Vortmeyer, Z. Zhuang, D. J. Venzon, F. Gibril, and R. T. Jensen Meningiomas May Be a Component Tumor of Multiple Endocrine Neoplasia Type 1 Clin. Cancer Res., February 1, 2004; 10(3): 869 - 880. [Abstract] [Full Text] [PDF]